Description: Shanghai Pharmaceuticals Holding Co., Ltd. engages research, development, manufacture, distribution, and retailing of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestive system, immune metabolism, motor neuron disease, endocrinology, cardiovascular, psychoneurotic, neoplasm, autoimmunity, systemic anti-infection, mental nerve, anti-tumor, oncology, respiratory system, nervous system, auto-immunity, hypertension, neuromyelitis, diabetes, anticholinesterase, polypeptide hormones uterine tonic, antihistamine, anti-inflammatory, anesthetic, immunomodulatory, antiviral, reflux esophagitis, analgesics, weight management, malignant peritoneal effusion, ulcerative colitis, myasthenia gravis, burn injury, anticoagulant, anti-epileptic, anticonvulsant, Alzheimer's, and inflammatory bowel diseases. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. The company was incorporated in 1994 and is headquartered in Shanghai, China.
Home Page: www.sphchina.com
Shanghai Pharmaceutical Building
Shanghai,
200020
China
Phone:
86 21 6373 0908
Officers
| Name | Title |
|---|---|
| Mr. Qiuhua Yang | Executive Chairman |
| Mr. Bo Shen CPA | President, CFO, Head of the Accounting Department & Executive Director |
| Mr. Yongzhong Li | VP & Executive Director |
| Mr. Ming Dong | Executive Director |
| Mr. Tao Zhong | VP, Board Secretary & Joint Company Secretary |
| Mr. Dongming Li | Vice President |
| Ms. Shuai Shao | Vice President |
| Dr. Shunjiang Yu | Chief Medical Officer |
| Ms. Pui Kiu Wong | Joint Company Secretary |
| Ying Ke | Director & General Manager of R&D Management Center |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Providers & Services |
| GIC Sub-Industry: | Health Care Distributors |
| Forward PE: | 10.2881 |
|---|---|
| Trailing PE: | 11.2857 |
| Price-to-Book MRQ: | 0.6354 |
| Price-to-Sales TTM: | 0.0338 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 48164 |